ArticlePharmaceutics2022

The Novel Peptide Chm-273s Has Therapeutic Potential for Metabolic Disorders: Evidence from In Vitro Studies and High-Sucrose Diet and High-Fat Diet Rodent Models.

Nikita A Mitkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.